PFIZER BIOTECH COPORATION

Business Nature: Manufacturing and Trading (It operates as a subsidiary of Pfizer Inc., engaging in both the local manufacturing of pharmaceutical products and the importation/distribution of global Pfizer products.)

Company Overview:

Pfizer Biotech Corporation is the Taiwan-based entity of the global pharmaceutical giant Pfizer Inc. The company is dedicated to the research, development, manufacturing, and commercialization of innovative medicines and vaccines. In Taiwan, it serves as a key hub for providing high-quality healthcare solutions, covering therapeutic areas such as oncology, inflammation and immunology, internal medicine, and vaccines. The company integrates local production capabilities with a robust supply chain network to ensure the availability of essential medical treatments for patients across the region. It adheres to strict international quality standards and plays an active role in collaborating with local medical institutions and health authorities to improve public health outcomes.

Pfizer Biotech Corporation Taiwan

Product Portfolio:

1. COMIRNATY (COVID-19 mRNA Vaccine)

2. PREVNAR 13 (Pneumococcal 13-valent Conjugate Vaccine)

3. ELAREX (Elacestrant)

4. IBRANCE (Palbociclib)

5. XELJANZ (Tofacitinib)

6. VYNDAQEL (Tafamidis)

7. ELIQUIS (Apixaban)

8. PREVENAR 20 (Pneumococcal 20-valent Conjugate Vaccine)

9. NUTRITROPIN (Somatropin)

10. GENOTROPIN (Somatropin)

Note: This list represents key pharmaceutical products marketed by Pfizer in Taiwan. Product availability may be subject to regulatory updates and local clinical guidelines.